Intelligent Bio Solutions (INBS) Receivables - Net (2021 - 2025)

Intelligent Bio Solutions has reported Receivables - Net for 5 years, with the latest figure at $594614.0 in Q2 2025.

• For the quarter ending Q2 2025, Receivables - Net rose 36.23% year-over-year to $594614.0; the trailing twelve-month figure through Jun 2025 stood at $594614.0 (up 36.23% YoY), and the FY2025 full-year result was $595160.0, up 36.36% from the prior year.
• Receivables - Net for Q2 2025 stood at $594614.0, up from $510963.0 in the prior quarter.
• The five-year high for Receivables - Net was $2.8 million in Q4 2021, with the low at $262834.0 in Q4 2023.
• Average Receivables - Net over 5 years is $1.0 million, with a median of $539236.5 recorded in 2023.
• Year-over-year, Receivables - Net slumped 89.89% in 2023 and surged 48.53% in 2024.
• Tracing INBS's Receivables - Net over 5 years: stood at $2.8 million in 2021, then slipped by 7.14% to $2.6 million in 2022, then tumbled by 89.89% to $262834.0 in 2023, then increased by 1.24% to $266080.0 in 2024, then surged by 123.47% to $594614.0 in 2025.
• The last three Receivables - Net figures came in at $594614.0 (Q2 2025), $510963.0 (Q1 2025), and $266080.0 (Q4 2024), per Business Quant data.

Peer Comparison